Kevin Chaplin
Kevin Chaplin is the CEO of Kardium Inc., a Vancouver-based medical device company specializing in innovative treatments for atrial fibrillation. Under his leadership, Kardium has developed a groundbreaking pulsed field ablation technology and recently raised $340 million to prepare for FDA approval and market entry.
Global Media Ratings
Countries Mentioned
No country-level mention data available.
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Canada:
Kevin Chaplin is the CEO of Kardium and is optimistic about receiving FDA approval for their heart device.
9